Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease

Park, Seung‐Jung; Ahn, Jung‐Min; Kim, Young‐Hak; Park, Duk‐Woo; Yun, Sung‐Cheol; Lee, Jong‐Young; Kang, Soo‐Jin; Lee, Seung‐Whan; Whan Lee, Cheol; Park, Seong‐Wook; Jung Choo, Suk; Hyun Chung, Cheol; Won Lee, Jae; J. Cohen, David; C. Yeung, Alan; Hur, Seung‐Ho; Bae Seung, Ki; Hoon Ahn, Tae; Moon Kwon, Hyuck; Lim, Do‐Sun; Rha, Seung‐Woon; Jeong, Myung‐Ho; Lee, Bong‐Ki; Tresukosol, Damras; Guo, Fu; Kiam Ong, Tiong

doi:10.1056/nejmoa1415447

Public

Trial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease

Published in New England Journal of Medicine • Mar 16, 2015

Authors:

Seung‐Jung Park

Jung‐Min Ahn

Young‐Hak Kim

Abstract

BACKGROUND: Most trials comparing percutaneous coronary intervention (PCI) with coronary-artery bypass grafting (CABG) have not made use of second-generation drug-eluting stents. METHODS: We conducted a randomized noninferiority trial at 27 centers in East Asia. We planned to randomly assign 1776 pa...

Subject

Medicine

Conventional PCI

Percutaneous coronary intervention

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!